Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Ascendis Pharma A/S (ASND) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$814.76M |
|
$-258.00M |
|
$107.39M |
|
$707.37M |
|
$968.93M |
|
$-154.18M |
|
$-86.42M |
|
$-240.59M |
|
$-240.59M |
|
$-258.00M |
|
$-258.00M |
|
$-258.00M |
|
$-258.00M |
|
$-154.18M |
|
$-134.16M |
|
60.61M |
|
60.61M |
|
$-4.25 |
|
$-4.25 |
|
| Balance Sheet Financials | |
$1.25B |
|
$165.73M |
|
$219.02M |
|
$1.47B |
|
$1.21B |
|
$435.88M |
|
$448.03M |
|
$1.66B |
|
$-184.22M |
|
$-188.41M |
|
$-184.22M |
|
61.98M |
|
| Cash Flow Statement Financials | |
$60.98M |
|
$-9.60M |
|
$41.10M |
|
$633.07M |
|
$696.99M |
|
$63.92M |
|
$131.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
1.73 |
|
-5.35 |
|
86.82% |
|
-18.92% |
|
-18.92% |
|
-16.47% |
|
-29.53% |
|
-31.67% |
|
$51.38M |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
0.31 |
|
4.57 |
|
79.93 |
|
140.05% |
|
136.93% |
|
-17.51% |
|
-102.52% |
|
$-2.97 |
|
$0.85 |
|
$1.01 |
|